Literature DB >> 15338298

Early onset Huntington disease: a neuronal degeneration syndrome.

Sara Seneca1, Domique Fagnart, Kathelijn Keymolen, Willy Lissens, Daniele Hasaerts, Sara Debulpaep, Brigitte Desprechins, Inge Liebaers, Linda De Meirleir.   

Abstract

UNLABELLED: Huntington disease (HD) is an autosomal dominant, lethal neurodegenerative disorder of the central nervous system, caused by an uncontrolled expansion of a CAG dynamic mutation in the coding region of the IT15gene. Although a majority of patients have a midlife onset of the disease, in a small number of patients the disease manifests before 20 years of age. In adults, HD is mainly characterised by involuntary movements, personality changes and dementia. By contrast, in children a dominant picture of bradykinesia, rigidity, dystonia and epileptic seizures is noticed. The earlier onset is often associated with a paternal transmission of the disease allele to the offspring. We report here a rather unusual infantile onset of the disease in a little girl who presented with a history of seizures and psychomotor regression starting at the age of 3 years. A progressive cortical-subcortical atrophy, progressive cerebellar atrophy and lesions in the basal ganglia were found on MRI. An important expansion, of 214 triplet numbers, of the CAG repeat size associated with HD, was observed.
CONCLUSION: Juvenile Huntingdon disease should be considered in children suffering from a progressive neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338298     DOI: 10.1007/s00431-004-1537-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease.

Authors:  M A Nance; V Mathias-Hagen; G Breningstall; M J Wick; R C McGlennen
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

Review 2.  Huntington's disease. Pathogenesis and management.

Authors:  J B Martin; J F Gusella
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

3.  Huntington disease in children: genotype-phenotype correlation.

Authors:  A Rasmussen; R Macias; P Yescas; A Ochoa; G Davila; E Alonso
Journal:  Neuropediatrics       Date:  2000-08       Impact factor: 1.947

4.  Genetic testing of children at risk for Huntington's disease. US Huntington Disease Genetic Testing Group.

Authors:  M A Nance
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

5.  A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes.

Authors:  J P Warner; L H Barron; D J Brock
Journal:  Mol Cell Probes       Date:  1993-06       Impact factor: 2.365

6.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

7.  Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent.

Authors:  H Telenius; H P Kremer; J Theilmann; S E Andrew; E Almqvist; M Anvret; C Greenberg; J Greenberg; G Lucotte; F Squitieri
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

8.  Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes.

Authors:  B Kremer; E Almqvist; J Theilmann; N Spence; H Telenius; Y P Goldberg; M R Hayden
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

9.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

10.  Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.

Authors:  Luc Djoussé; Beth Knowlton; Michael R Hayden; Elisabeth W Almqvist; Ryan R Brinkman; Christopher A Ross; Russel L Margolis; Adam Rosenblatt; Alexandra Durr; Catherine Dode; Patrick J Morrison; Andrea Novelletto; Marina Frontali; Ronald J A Trent; Elizabeth McCusker; Estrella Gómez-Tortosa; David Mayo Cabrero; Randi Jones; Andrea Zanko; Martha Nance; Ruth K Abramson; Oksana Suchowersky; Jane S Paulsen; Madaline B Harrison; Qiong Yang; L Adrienne Cupples; Jayalakshmi Mysore; James F Gusella; Marcy E MacDonald; Richard H Myers
Journal:  Neurogenetics       Date:  2004-03-17       Impact factor: 2.660

View more
  18 in total

1.  A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.

Authors:  Damian M Cummings; Yasaman Alaghband; Miriam A Hickey; Prasad R Joshi; S Candice Hong; Chunni Zhu; Timothy K Ando; Véronique M André; Carlos Cepeda; Joseph B Watson; Michael S Levine
Journal:  J Neurophysiol       Date:  2011-11-09       Impact factor: 2.714

Review 2.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

3.  RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.

Authors:  Scott Q Harper; Patrick D Staber; Xiaohua He; Steven L Eliason; Inês H Martins; Qinwen Mao; Linda Yang; Robert M Kotin; Henry L Paulson; Beverly L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-05       Impact factor: 11.205

Review 4.  Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.

Authors:  Carlos Cepeda; Katerina D Oikonomou; Damian Cummings; Joshua Barry; Vannah-Wila Yazon; Dickson T Chen; Janelle Asai; Christopher K Williams; Harry V Vinters
Journal:  J Neurosci Res       Date:  2019-07-28       Impact factor: 4.164

5.  Managing juvenile Huntington's disease.

Authors:  Oliver W J Quarrell; Martha A Nance; Peggy Nopoulos; Jane S Paulsen; Jonathan A Smith; Ferdinando Squitieri
Journal:  Neurodegener Dis Manag       Date:  2013-06-01

6.  Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.

Authors:  Jason Miller; Montserrat Arrasate; Benjamin A Shaby; Siddhartha Mitra; Eliezer Masliah; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-08-04       Impact factor: 6.167

Review 7.  Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.

Authors:  Carlos Cepeda; Damian M Cummings; Véronique M André; Sandra M Holley; Michael S Levine
Journal:  ASN Neuro       Date:  2010-04-07       Impact factor: 4.146

8.  Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.

Authors:  Damian M Cummings; Véronique M André; Besim O Uzgil; Steven M Gee; Yvette E Fisher; Carlos Cepeda; Michael S Levine
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

Review 9.  Huntington's Disease: Relationship Between Phenotype and Genotype.

Authors:  Yi-Min Sun; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

10.  RAN Translation in Huntington Disease.

Authors:  Monica Bañez-Coronel; Fatma Ayhan; Alex D Tarabochia; Tao Zu; Barbara A Perez; Solaleh Khoramian Tusi; Olga Pletnikova; David R Borchelt; Christopher A Ross; Russell L Margolis; Anthony T Yachnis; Juan C Troncoso; Laura P W Ranum
Journal:  Neuron       Date:  2015-11-18       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.